| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―May―21 |
Nirmatrelvir/Ritonavir Efficacy in Immunocompetent Patients with Confirmed Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2: An Updated Systematic Review and Meta-analysis |
Elnaz Khani, Hoda Afsharirad, Ali Taghizadeh Yadegari, Meysam Zarezadeh, Hila Asham, Hossein Bannazadeh-Baghi, Taher Entezari-Maleki |
| 2 |
[GO] |
2025―Apr―24 |
Comparative Efficacy of Atorvastatin and Placebo in Intensive Care Unit Patients with Coronavirus Disease 2019: A Randomized Controlled Trial |
Fatemeh Taghavi, Saeed Abbasi, Malihe Nejati, Shadi Farsaei |
| 3 |
[GO] |
2024―Sep―27 |
Is there a Possible Association between Multiple Myeloma Relapse and Coronavirus Disease 2019 Vaccination? A Case Report |
Nasrin Shirzad-Yazdi, Nasrin Namdari, Anahid Noorani, Iman Karimzadeh |
| 4 |
[GO] |
2024―Aug―06 |
Efficacy of Licorice as Adjunctive Therapy in Critically Ill Patients with COVID-19: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial |
Babak Alikiaie, Seyed Mohammad Hosseinian Shalamzari, Rasool Soltani, Afsaneh Yegdaneh, Sarah Mousavi |
| 5 |
[GO] |
2023―Aug―28 |
Efficacy and safety comparison of two different doses of dexamethasone in hospitalized patients with COVID-19: A randomized clinical trial |
MarziehMollaei Ardestani, Somayeh Sadeghi, Nima Arezoomandi, MohammadEmami Ardestani, Farzin Ghiasi, Ziba Farajzadegan |
| 6 |
[GO] |
2022―Dec―13 |
High-dose intravenous Vitamin C in early stages of severe acute respiratory syndrome coronavirus 2 infection: A double-blind, randomized, controlled clinical trial |
Kourosh Sadeghi, Zohre Labbani-Motlagh, Shahideh Amini, Rasoul Aliannejad, Anahita Sadeghi, Gita Shafiee, et al. (+6) Ramin Heshmat, Mohamadreza Jafary, Mona Talaschian, Maryam Akhtari, Ahmadreza Jamshidi, Mahdi Mahmoudi |
| 7 |
[GO] |
2022―Aug―18 |
Community pharmacists' services during the COVID-19 pandemic: A case study of Lagos State, Nigeria |
OgochukwuU Amaeze, AlexanderA Akinola, AyobamiA Aiyeolemi, FolasadeO Lawal, OghoghoR Ijomone, UgochukwuA Mbata |
| 8 |
[GO] |
2022―Aug―18 |
Evaluation of COVID-19 treatments in Iran in comparison with local therapeutic recommendations: A population-level study on utilization and costs of prescription drugs |
Saeed Yaghoubifard, Amir Hashemi-Meshkini, Reza Koochak, Shekoufeh Nikfar, Ehsan Rezaei-Darzi |
| 9 |
[GO] |
2022―Aug―18 |
Knowledge and compliance of hydroxychloroquine prophylaxis for severe acute respiratory syndrome coronavirus 2 infection among Indian health-care workers |
Mohan Gurjar, Rudrashish Haldar, Prabhaker Mishra, OmPrakash Sanjeev, VijaiDatta Upadhyaya, Ankur Bhatnagar, et al. (+2) Dharmendra Bhadauria, Vikas Agarwal |
| 10 |
[GO] |
2021―Dec―24 |
Summary of COVID-19 vaccine-related reports in the vaccine adverse event reporting system |
AliceC Ceacareanu, ZacharyA. P. Wintrob |
| 11 |
[GO] |
2021―May―05 |
Changes in availability, utilization, and prices of medicines and protection equipment for COVID-19 in an Urban population of Northern Nigeria |
Brian Godman, Mainul Haque, AbdullahiRabiu Abubakar, OlayinkaO Ogunleye, IbrahimHaruna Sani, Israel Sefah, et al. (+2) Amanj Kurdi, Salequl Islam |
| 12 |
[GO] |
2021―May―05 |
Strategic role and challenges of community pharmacists in SARS-CoV-2 outbreak |
MadanMohan Gupta, Debjyoti Talukdar, Satish Jankie, ShyamSundar Pancholi, Arindam Chatterjee, Parveen Kumar |
| 13 |
[GO] |
2020―Oct―08 |
Increased risk of arrhythmia in COVID-19 patients: Possible roles of both the disease pathophysiology and adverse drug reactions |
Ali Rismanbaf |
| 14 |
[GO] |
2020―Oct―08 |
Challenges of non-COVID-19 patients with chronic illness during the pandemic |
ThangavelMahalingam Vijayakumar, MuhasaparurGanesan Rajanandh, DebiAnn Abraham |
